Metraipolis › archive › dc_f0cf0ffd6d16

Comparing long-term value creation after biotech and non-biotech IPOs, 1997-2016 — Europe PMC PMID:33406113

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33406113
DOI
10.1371/journal.pone.0243813
License (as archived)
solo-consultazione
Archived
2026-10-08T02:09:16.697Z
SHA-256 of the archived text
2a266c01bd949878fc8b486006803f354e418dc34ff5321284a2ce589a357f21
Stable URL of this page
https://metraipolis.com/documento/dc_f0cf0ffd6d16

How to cite

Comparing long-term value creation after biotech and non-biotech IPOs, 1997-2016 — Europe PMC PMID:33406113 — Europe PMC (en), https://europepmc.org/article/MED/33406113 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f0cf0ffd6d16 (Metraipolis archive dc_f0cf0ffd6d16, sha256 2a266c01bd949878fc8b486006803f354e418dc34ff5321284a2ce589a357f21)
BibTeX
@misc{dcf0cf0ffd6d16,
  title = {Comparing long-term value creation after biotech and non-biotech IPOs, 1997-2016 — Europe PMC PMID:33406113},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33406113},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f0cf0ffd6d16; sha256 2a266c01bd949878fc8b486006803f354e418dc34ff5321284a2ce589a357f21},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/33406113. Agents can read the archived copy with the MCP tool read_document.